Whilst low cost cards may also help relieve the burden of significant drug expenses within the temporary, they do not handle the systemic issues driving up prescription charges while in the U.S. Broader plan adjustments could tackle the root causes of growing drug costs, including lack of transparency in pricing as well as the role of intermediarie